Vascular Medicine

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loftus, I.
Right arrow Articles by Thompson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loftus, I.
Right arrow Articles by Thompson, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Vascular Medicine, Vol. 7, No. 2, 117-133 (2002)
DOI: 10.1191/1358863x02vm420ra

The role of matrix metalloproteinases in vascular disease

IM Loftus

Department of Surgery, Leicester University, Leicester, UK, ianloftus{at}aol.com

MM Thompson

Department of Surgery, Leicester University, Leicester, UK

There is growing interest in the role of matrix metalloproteinasesin vascular diseases. These conditions are often characterized by excessive tissue remodelling, and increased matrix metalloproteinase activity has been demonstrated in aneurysms, intimal hyperplasia and atherosclerotic plaque disruption. These enzymes represent a potential target for therapeutic intervention to modify vascular pathology.

The core of this review is derived from a MEDLINE database literature search. The review found that there is convincing evidence of increased matrix metalloproteinase activity in a spectrum of vascular disease. Evidence for an imbalance promoting increased matrix degradation is less well documented. However, studies of matrix metalloproteinase inhibition in vascular disease models suggest potential therapeutic benefit.

In conclusion, in vivo studies of matrix metalloproteinase inhibition are required to further study the potential for reversal or deceleration of the excessive tissue remodelling that accompanies vascular disorders.

Key Words: aneurysm • atherosclerosis • intimal hyperplasia • matrix metalloproteinase


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 StrokeHome page
F. Pico, J. Labreuche, D. Seilhean, C. Duyckaerts, J.-J. Hauw, and P. Amarenco
Association of Small-Vessel Disease With Dilatative Arteriopathy of the Brain: Neuropathologic Evidence
Stroke, April 1, 2007; 38(4): 1197 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Sangiorgi, A. Mauriello, E. Bonanno, C. Oxvig, C. A. Conover, M. Christiansen, S. Trimarchi, V. Rampoldi, D. R. Holmes Jr, R. S. Schwartz, et al.
Pregnancy-Associated Plasma Protein-A Is Markedly Expressed by Monocyte-Macrophage Cells in Vulnerable and Ruptured Carotid Atherosclerotic Plaques: A Link Between Inflammation and Cerebrovascular Events
J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2201 - 2211.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
N. K. Schiller, A. S. Black, G. P. Bradshaw, D. J. Bonnet, and L. K. Curtiss
Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice
J. Lipid Res., August 1, 2004; 45(8): 1398 - 1409.
[Abstract] [Full Text] [PDF]